New drug combo aims to free CML patients from lifelong pills
NCT ID NCT06368414
First seen Apr 09, 2026 · Last updated Apr 16, 2026 · Updated 1 time
Summary
This study tests whether adding a newer drug called asciminib to standard CML medications can help patients achieve and maintain a medication-free period. It is for adults with chronic-phase CML who previously tried to stop their medication but saw their cancer markers return. The goal is to help patients safely stop all treatment for extended periods while keeping the cancer under control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gachon University Gil Medical Center
RECRUITINGIncheon, Incheon, 21565, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.